Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.

The webinar will be held on Wednesday 9th October 2024 at 19:00 for 45 minutes. Chaired by Katherine Hickman (our PCRS Executive Chair), she and guest speaker, Noreen Grant (GP), will focus on:

Concerns about the environmental impact of the propellant gases used in pressurised metered dose inhalers (pMDIs) and the plastics used in all single-use inhaler devices have made them an important focus for efforts to reduce the environmental impact of the NHS.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has for the first time approved the use of a dual (ICS/beta-agonist) combination treatment to be prescribed as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an

This edition sees a focus on antibiotics – a hardy perennial topic that requires regular re-visitation. Whether for respiratory infections or as part of rescue pack use, the practical guidance given, together with the views of patients, aims to support your decision-making in practice.

Vikki Knowles - Surrey: Minimising MDIs Independent Respiratory Nurse Specialist Vikki Knowles shares the early stages of work being done to minimise the use of Metered Dose Inhalers (MDIs) in their practice in Surrey and how that can positively impact the greener healthcare environment

Dr Kat Parker - Bristol: Switching to DPIs In this case study from Dr Kat Parker, she shares her experience of how her practice in Bristol has been switching patients from Metered Dose Inhalers (MDIs) to Dry Powder Inhalers (DPIs) where appropriate to do so, when and how they communicat

In this episode specialist respiratory nurses Viv Marsh (Paediatric Asthma Nurse Specialist, Dudley, West Midlands), Rebecca Bryson (Children's Respiratory Nurse specialising in Asthma and Allergy, Arrowe Park Teaching Hospital, The Wirral) and Lesley Kennedy (Asthma and Allergy Nurse Specia

In this episode Steve Holmes and Jane Scullion discuss optimising inhaler use and inhaler therapies. They share tips and advice on selecting inhalers taking into account important factors to be considered. Have you got views on inhalers?

Asthma Right Care (ARC) is a global initiative led by the International Primary Care Respiratory Group (IPCRG) to explore how to use social movement approaches to create a sense of discomfort and dissatisfaction with the status quo in the management of asthma in a manner that’s positive and creat

Welcome to the Summer 2021 edition of Primary Care Respiratory Update. In this publication, and in keeping with the weather outside, we are providing a focus on climate, Global Warming, and the environment.

In this article we discuss how to incorporate environmental considerations when selecting inhaler devices for patients newly diagnosed with respiratory disease.

Get ready for winter now... The COVID-19 pandemic has caused a huge amount of upheaval and changed the way we live our lives in a very short space of time.

Dr Duncan Keeley and Prof Martin Partridge have set out that there are advantages of separating out the routine inhaled treatment of asthma and COPD from that needed in more acute situations.

The least cost-effective inhaler device is the one that the patient cannot use. In deciding which device and drug formulation to prescribe healthcare professionals should first determine the patient’s ability to use the prescribed device correctly.